Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Change in Accured Expenses (2016 - 2021)

Historic Change in Accured Expenses for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q4 2021 value amounting to $599000.0.

  • Phio Pharmaceuticals' Change in Accured Expenses rose 270434.78% to $599000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.3 million, marking a year-over-year increase of 21566.27%. This contributed to the annual value of -$180000.0 for FY2024, which is 11686.75% down from last year.
  • Phio Pharmaceuticals' Change in Accured Expenses amounted to $599000.0 in Q4 2021, which was up 270434.78% from -$49000.0 recorded in Q3 2021.
  • Over the past 5 years, Phio Pharmaceuticals' Change in Accured Expenses peaked at $652000.0 during Q2 2021, and registered a low of -$649000.0 during Q3 2018.
  • Over the past 5 years, Phio Pharmaceuticals' median Change in Accured Expenses value was $95500.0 (recorded in 2020), while the average stood at $51850.0.
  • Per our database at Business Quant, Phio Pharmaceuticals' Change in Accured Expenses tumbled by 44521.28% in 2018 and then surged by 270434.78% in 2021.
  • Quarter analysis of 5 years shows Phio Pharmaceuticals' Change in Accured Expenses stood at -$147000.0 in 2017, then plummeted by 154.42% to -$374000.0 in 2018, then soared by 71.66% to -$106000.0 in 2019, then surged by 78.3% to -$23000.0 in 2020, then soared by 2704.35% to $599000.0 in 2021.
  • Its last three reported values are $599000.0 in Q4 2021, -$49000.0 for Q3 2021, and $652000.0 during Q2 2021.